202 related articles for article (PubMed ID: 36530430)
1. The human oral - nasopharynx microbiome as a risk screening tool for nasopharyngeal carcinoma.
Hao Y; Zeng Z; Peng X; Ai P; Han Q; Ren B; Li M; Wang H; Zhou X; Zhou X; Ma Y; Cheng L
Front Cell Infect Microbiol; 2022; 12():1013920. PubMed ID: 36530430
[TBL] [Abstract][Full Text] [Related]
2. Nasopharyngeal brushing: a convenient and feasible sampling method for nucleic acid-based nasopharyngeal carcinoma research.
Zhang PF; Zheng XH; Li XZ; Tian T; Zhang SD; Hu YZ; Jia WH
Cancer Commun (Lond); 2018 Apr; 38(1):8. PubMed ID: 29764493
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of circulating EBV microRNA BART2-5p in facilitating early detection and screening of nasopharyngeal carcinoma.
Jiang C; Chen J; Xie S; Zhang L; Xiang Y; Lung M; Kam NW; Kwong DL; Cao S; Guan XY
Int J Cancer; 2018 Dec; 143(12):3209-3217. PubMed ID: 29971780
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the nasopharynx microbiota in patients with nasopharyngeal carcinoma vs. healthy controls.
Li L; Deng X; Zou Y; Lv X; Guo Y
Braz J Microbiol; 2021 Dec; 52(4):1873-1880. PubMed ID: 34491569
[TBL] [Abstract][Full Text] [Related]
5. Utility of Epstein-Barr Virus DNA in Nasopharynx Swabs as a Reflex Test to Triage Seropositive Individuals in Nasopharyngeal Carcinoma Screening Programs.
Chen GH; Liu Z; Yu KJ; Coghill AE; Chen XX; Xie SH; Lin DF; Huang QH; Lu YQ; Ling W; Lin CY; Lu ZJ; Fan YY; Tang LQ; Sampson JN; Li H; King AD; Middeldorp JM; Hildesheim A; Cao SM
Clin Chem; 2022 Jul; 68(7):953-962. PubMed ID: 35325087
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.
Stevens SJ; Verkuijlen SA; Hariwiyanto B; Harijadi ; Paramita DK; Fachiroh J; Adham M; Tan IB; Haryana SM; Middeldorp JM
Int J Cancer; 2006 Aug; 119(3):608-14. PubMed ID: 16572427
[TBL] [Abstract][Full Text] [Related]
7. Waldeyer ring microbiome in relation to chemoradiation-induced oral mucositis in patients with nasopharyngeal carcinoma.
Chung A; Chung YT; Liang YW; Chung YL
Head Neck; 2023 Aug; 45(8):2047-2057. PubMed ID: 37337976
[TBL] [Abstract][Full Text] [Related]
8. [The clinical significance of EBV DNA analysis in nasopharyngeal carcinoma screening].
Wang L; Song YL; Huang SM; Tao HX; Zhao YQ; Yan N; Xu DY
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 32(4):298-301. PubMed ID: 29798510
[No Abstract] [Full Text] [Related]
9. A comparison of EBV serology and serum cell-free DNA as screening tools for nasopharyngeal cancer: Results of the Singapore NPC screening cohort.
Tay JK; Siow CH; Goh HL; Lim CM; Hsu PP; Chan SH; Loh KS
Int J Cancer; 2020 May; 146(10):2923-2931. PubMed ID: 31705522
[TBL] [Abstract][Full Text] [Related]
10. Detection of methylation status of Epstein-Barr virus DNA C promoter in the diagnosis of nasopharyngeal carcinoma.
Zheng XH; Wang RZ; Li XZ; Zhou T; Zhang JB; Zhang PF; Lu LX; Jia WH
Cancer Sci; 2020 Feb; 111(2):592-600. PubMed ID: 31834989
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of nasal and nasopharyngeal swab collection for the detection of Epstein-Barr virus in nasopharyngeal carcinoma.
Coghill AE; Wang CP; Verkuijilen SAWM; Yu KJ; Hsu WL; Middeldorp JM; Hildesheim A
J Med Virol; 2018 Jan; 90(1):191-195. PubMed ID: 28833336
[TBL] [Abstract][Full Text] [Related]
12. Cell-free EBV DNA as a biomarker during clinical management of nasopharyngeal carcinoma in a nonendemic region.
Pramanik R; Arora S; Sharma P; Biswas A; Nayak B; Thakar A; Sharma A; Ghose S
J Med Virol; 2022 Feb; 94(2):720-728. PubMed ID: 34750844
[TBL] [Abstract][Full Text] [Related]
13.
Lyu JY; Chen JY; Zhang XJ; Zhang MW; Yu GS; Zhang L; Wen Z
Dis Markers; 2020; 2020():7253531. PubMed ID: 32454907
[TBL] [Abstract][Full Text] [Related]
14. Changes of saliva microbiota in nasopharyngeal carcinoma patients under chemoradiation therapy.
Xu Y; Teng F; Huang S; Lin Z; Yuan X; Zeng X; Yang F
Arch Oral Biol; 2014 Feb; 59(2):176-86. PubMed ID: 24370189
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.
Ramayanti O; Juwana H; Verkuijlen SA; Adham M; Pegtel MD; Greijer AE; Middeldorp JM
Int J Cancer; 2017 Jan; 140(1):149-162. PubMed ID: 27600027
[TBL] [Abstract][Full Text] [Related]
16. Screening nasopharyngeal carcinoma by detection of the latent membrane protein 1 (LMP-1) gene with nasopharyngeal swabs.
Hao SP; Tsang NM; Chang KP
Cancer; 2003 Apr; 97(8):1909-13. PubMed ID: 12673717
[TBL] [Abstract][Full Text] [Related]
17. Multiplex Epstein-Barr virus BALF2 genotyping detects high-risk variants in plasma for population screening of nasopharyngeal carcinoma.
Miller JA; Sahoo MK; Yamamoto F; Huang C; Wang H; Zehnder JL; Le QT; Pinsky BA
Mol Cancer; 2022 Jul; 21(1):154. PubMed ID: 35902864
[TBL] [Abstract][Full Text] [Related]
18. Nasopharyngeal swab and PCR for the screening of nasopharyngeal carcinoma in the endemic area: a good supplement to the serologic screening.
Sheen TS; Ko JY; Chang YL; Chang YS; Huang YT; Chang Y; Tsai CH; Hsu MM
Head Neck; 1998 Dec; 20(8):732-8. PubMed ID: 9790296
[TBL] [Abstract][Full Text] [Related]
19. Complementary roles of MRI and endoscopic examination in the early detection of nasopharyngeal carcinoma.
King AD; Woo JKS; Ai QY; Chan JSM; Lam WKJ; Tse IOL; Bhatia KS; Zee BCY; Hui EP; Ma BBY; Chiu RWK; van Hasselt AC; Chan ATC; Lo YMD; Chan KCA
Ann Oncol; 2019 Jun; 30(6):977-982. PubMed ID: 30912815
[TBL] [Abstract][Full Text] [Related]
20. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J
Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
